Home » Topics » Conferences

Conferences
RSS

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

COX-2 inhibitor reported by Searle

April 12, 1996

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Conjugated estrogens + pravastatin effective in treating hypercholesterolemia in women

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...